---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-23-000036"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:28:54.232010+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CV Sciences Q3 revenue $4.1M (+9% YoY); margin expands; signs LOI for European acquisition

## Summary
- Revenue $4.1M, +9% YoY from $3.8M; gross margin 45.1% vs 41.6%.
- Operating loss narrowed to $0.4M from $0.9M; adjusted EBITDA -$0.4M vs -$1.2M.
- Cash balance $1.6M (up from $0.6M end 2022); operating cash flow $2.4M (incl. $2.5M ERC).
- Signed non-binding LOI to acquire a plant-based food company in Europe as part of new M&A strategy.
- Maintained #1 hemp extract brand in natural retail; launched PlusCBD Reserve Sleep Gummies.

## SEC filing metadata
- accession: 0001510964-23-000036
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000036/0001510964-23-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000036/cvsi-20231114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-23-000036
- JSON: https://secwatch.observer/filing/0001510964-23-000036.json
- Plain text: https://secwatch.observer/filing/0001510964-23-000036.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the quarter ended September 30, 2023 results: revenue $4.1 million.
  - Period: the quarter ended September 30, 2023
  - Revenue: $4.1 million
  - Result: reported results
  source text: products, today announced its financial results for the quarter ended September 30, 2023. Third Quarter 2023 and Recent Financial and Operating Highlights • Increased revenue to $4.1 million for the third quarter 2023 compared to $3.8 million for third quarter 2022 and a sequential improvement from $4.0 million for the second quarter 2023; • Recognized gross margin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000151096423000036/0001510964-23-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.